About Sofosbuvir 400 mg and Daclatasvir 60 mg
Hepcinat Plus, Sofosbuvir 400 mg and Daclatasvir 60 mg tablet a combination medication that is used to treat chronic liver C virus (HCV) infection. It reduces the quantity of hepatitis C viruses that are present in the body, and then getting rid of the virus from blood over a certain period of time.
Hepcinat Plus Sofosbuvir 400 mg and Daclatasvir 60 mg is to take without or with food at a set time every day to ensure regular levels of the medicine in blood. If you forget the dose of this medication then take it whenever you remember.
Don’t skip doses, and make sure you finish the entire treatment, even the moment you are feeling better. It is essential not to discontinue taking the medication immediately as it can aggravate the symptoms.
Hepcinat Plus, 60mg/400 mg Tablet could cause adverse reactions such as headache, nausea, or fatigue. Inform your physician if these adverse effects don’t disappear or last for a longer time. It is recommended to consult your doctor when you are planning to have a baby or are breastfeeding.
Benefits of Sofosbuvir 400 mg and Daclatasvir 60 mg:
Hepatitis C is an infection of the liver caused by hepatitis C virus (HCV). If the disease progresses into an extended stage, it’s known as chronic hepatitis C virus disease.
Hepcinat Plus is a Sofosbuvir 400 mg and Daclatasvir 60 mg tablet that can help to reduce the prevalence of Hepatitis C virus by stopping the spread of these viruses within your body. This aids in controlling the infection and aids in recovering faster. It is essential to follow the prescribed dosage and in accordance with the dosage suggested by your doctor.
How to use:
You should take this medication at the dosage and duration prescribed by your physician. Inhale it all in one go. Don’t chew or crush it. Do not break it. Hepcinat Plus Sofosbuvir 400 mg and Daclatasvir 60 mg Tablet can take either with or without food, but it’s best to consume it at a specific time.
Hepcinat Plus, 60mg/400mg tablet is a mixture of two medications. Daclatasvir as well as Sofosbuvir, are both antiviral drugs. They reduce the amount of hepatitis C virus within the body and eliminating the virus from blood over a certain time.